- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Profitable Climbers
Danish Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
ChemoMetec
Market Cap: DKK 12.4b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 712.00
7D
0.07%
1Y
36.4%
Genmab
Market Cap: DKK 134.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,185.00
7D
0.1%
1Y
44.7%